The Aha! Factor

In one of my pathology lab courses for second-year medical students, we were reviewing the gross and microscopic findings from the autopsy of a patient who had died following acute pulmonary embolism. As I was going through the features that help one distinguish an ante-mortem thrombus vs. a postmortem clot, one of my more outspoken students said sardonically, "This will help me take better care of my patients!" That comment raised, at least in my mind, a question that I've been wrestling with

Written byTv Rajan
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

That comment raised, at least in my mind, a question that I've been wrestling with over the last several years: Why do we teach what we do?

It is interesting how much my own attitude toward this question has changed over the years. There was a time when I felt that a thorough grounding in basic biological knowledge is absolutely critical to being an adequate physician. This premise, that understanding the basic vocabulary of biology is critical to a physician's education, underlay my attitude toward the basic biomedical curriculum for many years. I was convinced, for instance, that genetic information would have such a major impact on understanding pathology, predicting prognosis, and designing therapy that a thorough grounding in molecular genetics was critical to be a well-informed physician in the 21st century.

It is ironic that even as I thought this, I was not paying heed to the fact that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies